• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,518.49
  • 0.78 %
  • $297.86
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Aerie Pharmaceuticals, Inc. (AERI) Stock Price, News & Analysis

Aerie Pharmaceuticals, Inc. (AERI) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$15.24
Day's range
$15.25
50-day range
$15.04
Day's range
$15.26
  • Country: US
  • ISIN: US00771V1089
52 wk range
$4.81
Day's range
$15.37
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score N/A
  • Piotroski Score N/A
  • Grade Neutral
  • Symbol (AERI)
  • Company Aerie Pharmaceuticals, Inc.
  • Price $15.25
  • Changes Percentage (0%)
  • Change -$0
  • Day Low $15.24
  • Day High $15.25
  • Year High $15.37

Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) N/A
  • Fiscal Year End N/A

  • Average Stock Price Target $15.25
  • High Stock Price Target $15.25
  • Low Stock Price Target $15.25
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.00
  • Trailing P/E Ratio 0
  • Forward P/E Ratio 0
  • P/E Growth 0
  • Net Income $-74,810,000

Income Statement

Quarterly

Annual

Latest News of AERI

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Aerie Pharmaceuticals, Inc. Frequently Asked Questions

  • What were the earnings of AERI in the last quarter?

    In the last quarter Aerie Pharmaceuticals, Inc. earnings were on Thursday, November, 3rd. The Aerie Pharmaceuticals, Inc. maker reported -$0.27 EPS for the quarter, beating analysts' consensus estimates of -$0.44 by $0.17.

  • What is the Aerie Pharmaceuticals, Inc. stock price today?

    Today's price of Aerie Pharmaceuticals, Inc. is $15.25 — it has decreased by 0% in the past 24 hours. Watch Aerie Pharmaceuticals, Inc. stock price performance more closely on the chart.

  • Does Aerie Pharmaceuticals, Inc. release reports?

    Yes, you can track Aerie Pharmaceuticals, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Aerie Pharmaceuticals, Inc. stock forecast?

    Watch the Aerie Pharmaceuticals, Inc. chart and read a more detailed Aerie Pharmaceuticals, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Aerie Pharmaceuticals, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Aerie Pharmaceuticals, Inc. stock ticker.

  • How to buy Aerie Pharmaceuticals, Inc. stocks?

    Like other stocks, AERI shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Aerie Pharmaceuticals, Inc.'s EBITDA?

    Aerie Pharmaceuticals, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Aerie Pharmaceuticals, Inc.’s financial statements.

  • What is the Aerie Pharmaceuticals, Inc.'s net income ratio for the financial year 2021?

    The net income ratio for the financial year 2021 is -0.3853523855, which equates to approximately -38.54%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Aerie Pharmaceuticals, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Aerie Pharmaceuticals, Inc.'s financials relevant news, and technical analysis. Aerie Pharmaceuticals, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Aerie Pharmaceuticals, Inc. stock currently indicates a “sell” signal. For more insights, review Aerie Pharmaceuticals, Inc.’s technical analysis.

  • A revenue figure for Aerie Pharmaceuticals, Inc. for its last quarter?

    Aerie Pharmaceuticals, Inc. published it's last quarterly revenues at $36.13 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.